Thomas Helleday on Cancer

For the Inaugural Radcliffe Lecture 2014 Professor Hugh Watkins explores the success and limitations of genome sequencing in simple Mendelian diseases and in complex disorders, against the backdrop of his ground breaking research into heart disease. The Radcliffe Lecture series p ... Show More

Professor Irene Tracey talks about her research into pain through using brain imaging technology to see exactly how the brain is affected by pain while discussing its implications to how we understand pain in society. 

Professor Smith talks about his research at OPTIMA (Oxford Project To Investigate Memory and Ageing) on dementia, particularly Alzheimer's and the relation between diet and blood pressure in younger life and dementia in older life. 

Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. Immunotherapy stimulates the body's immune system, and can be a powerful treatment for cancer. The most efficient prophylactic cancer vaccine today is the vaccine a ... Show More

Cancer treatment has come a long way in recent decades. But finding the best course of treatment for each case of this diverse, dynamic disease remains a challenge. In this episode, co-host Steven Strogatz speaks with computational biologist Franziska Michor about how math, stati ... Show More

Have you listened to the FULL EPISODE yet?"At this point, the World Health Organization considers 13 different types of cancer as obesity-related cancers, which is huge because from 2003, we didn't even know. When I went to medical school, nobody thought obesity caused cancer. It ... Show More

La recherche en cancérologie a fortement progressé ses dernières années, grâce notamment à une meilleure compréhension des mécanismes à l’origine de la maladie. Un diagnostic précoce et une meilleure prise en charge permettent aussi de mieux soigner la population. Mais le vieilli ... Show More

The Cancer Moonshot initiative, launched under the Obama administration, was audacious by design: Supercharge cancer research to encourage innovation, with the mission “to end to cancer as we know it.” Cancer researchers avoid using the word “cure.” From studying cancer at the mo ... Show More

Diagnosing cancer in primary care is difficult. Many patients present with non-specific symptoms and the positive predictive value of even the ‘red flag’ symptoms is low. In this podcast, Dr Thomas Round and Professor Willie Hamilton discuss the issues around cancer diagnosis in ... Show More

Dr. Patrick Soon-Shiong is a surgeon who made billions inventing cancer drugs. He says that Covid, and the vaccines that didn’t stop it, are likely causing a global epidemic of terrifyingly aggressive cancers. (00:00) Why Are Cancer Rates Rising in Young People?(06:16) What Is Ca ... Show More

Identifying genes that increase the risk of bowel or other cancers allows us to offer preventative measures, such as removing tumours at an early stage. A better understanding of how and why cancers grow also helps develop improved treatments. Ian Tomlinson, Professor of Molecula ... Show More

What does it take to improve quality of life after head and neck cancer? In this episode of Backtable ENT, guests Dr. Heather Starmer, a speech and language pathologist at Stanford University, and Dr. Michael Moore, a head and neck cancer surgeon at Indiana University explore the ... Show More